Loading...
XASXIME
Market cap9mUSD
Dec 30, Last price  
0.33AUD
1D
-8.33%
1Q
-31.25%
IPO
-100.00%
Name

ImExHS Ltd

Chart & Performance

D1W1MN
XASX:IME chart
P/E
—
P/S
0.77
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
25.93%
Rev. gr., 5y
27.75%
Revenues
20m
+14.91%
18,169,0006,374,0005,065,00012,028,0000000091,02080,1173,545,8495,779,8517,736,28710,913,96813,372,70917,117,35719,669,043
Net income
-4m
L+37.97%
-13,898,000-29,499,000-1,904,000-1,418,000-344,552691,239-492,610-190,266-121,905-2,830,304-4,490,93568,469-4,887,165-6,002,288-3,615,977-4,699,772-3,038,653-4,192,339
CFO
3m
P
000-2,657,513000000-3,651,460-109,862-1,541,439-4,089,807-1,467,042-2,968,041-2,198,7382,609,641
Earnings
Jan 28, 2025

Profile

ImExHS Limited offers cloud-based medical imaging solutions in Australia and internationally. It offers a medical imaging software that is focused on the development and sale of modular imaging systems, which include information systems for radiology, cardiology, and pathology, as well as a picture archiving and communications system. The company's solutions include AQUILA, a radiology software solution; ALULA, a pathology software solution; Antero, a cardiology software solution; and STELLA.I, a set of artificial intelligence tools in the cloud that support specialists in the diagnosis. It also provides outsourced radiology services for hospitals and other establishments, as well as teleradiology services. The company was incorporated in 2001 and is based in Mascot, Australia.
URL
http://omnimarkettide.com/
IPO date
Dec 14, 2005
Employees
300
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
19,669
14.91%
17,117
28.00%
Cost of revenue
18,930
20,881
Unusual Expense (Income)
NOPBT
739
(3,763)
NOPBT Margin
3.76%
Operating Taxes
173
92
Tax Rate
23.36%
NOPAT
567
(3,856)
Net income
(4,192)
37.97%
(3,039)
-35.34%
Dividends
Dividend yield
Proceeds from repurchase of equity
(13)
3,250
BB yield
0.05%
-19.84%
Debt
Debt current
1,077
574
Long-term debt
243
572
Deferred revenue
543
Other long-term liabilities
(543)
Net debt
(1,041)
(1,394)
Cash flow
Cash from operating activities
2,610
(2,199)
CAPEX
(1,231)
(2,031)
Cash from investing activities
(2,133)
(2,222)
Cash from financing activities
(99)
2,252
FCF
1,086
(4,523)
Balance
Cash
2,362
1,912
Long term investments
628
Excess cash
1,378
1,684
Stockholders' equity
15,984
15,901
Invested Capital
15,898
15,309
ROIC
3.63%
ROCE
4.26%
EV
Common stock shares outstanding
41,738
35,600
Price
0.67
45.65%
0.46
-55.34%
Market cap
27,964
70.77%
16,376
-48.81%
EV
26,924
14,982
EBITDA
3,169
(2,004)
EV/EBITDA
8.50
Interest
332
443
Interest/NOPBT
44.93%